Colorectal cancer is the third most common malignancy and the third most common cause of
cancer-related death in the United States. 1 Surgical resection remains the primary …

Despite the technical limitations of minimally invasive surgery, laparoscopic total mesorectal
excision (LTME) for rectal cancer has short-term advantages over open surgery, but the …

Aim There are no studies on the respective influence of microscopic involvement at the
circumferential (R1c) and the distal margin (R1d) of the surgical specimen on oncological …

Background This systematic review sought to compare the urogenital functions after
laparoscopic (LAP) and robotic (ROB) surgery for rectal cancer. Methods This study …

Background No effective treatment exists for anterior resection syndrome (ARS) following
sphincter-saving surgery for rectal cancer. This RCT assessed the safety and efficacy of a 5 …

Purpose Today, the rapid outbreak of COVID-19 is the leading health issue. Patients with
cancer are at high risk for the development of morbidities of COVID-19. Hence, oncology …

Introduction Colorectal cancer (CRC) is a major health concern and it is associated with
significant morbidity and mortality. Over the last decades, the relationship between cancer …

Colorectal cancer (CRC) is the third leading malignancy worldwide in both new cases and
deaths. Neoadjuvant radiotherapy is the standard preoperative regimens for locally …

Incorporation of new treatment modalities has significantly increased the complexity of the
treatment and management of rectal cancer, including perioperative therapy for local …

Since the advent of laparoscopy, minimally invasive techniques such as single port
laparoscopy, robotics, endoscopically assisted laparoscopy, and transanal endoscopic …